DT2216
CAS: 2365172-42-3
Ref. 3D-QUD17242
1mg | 455,00 € | ||
2mg | 711,00 € | ||
5mg | 1.276,00 € | ||
10mg | 2.041,00 € | ||
500µg | 341,00 € |
Información del producto
DT2216 is a molecule that inhibits the ubiquitin-proteasome system (UPS) and regulates protein levels. DT2216 has been shown to have potent antitumor activity in animal models of cancer, including breast, colon, and lung cancers. This drug has also been shown to inhibit the growth of leukemia cells and t-cell lymphomas in cell culture. The mechanism of action appears to be related to the ability of DT2216 to impair the function of cytosolic protein kinase C (PKC), which is involved in tumor cell proliferation and survival. DT2216 has been found to synergize with other drugs used for cancer treatment such as vincristine, carboplatin, paclitaxel, cisplatin, tamoxifen, or docetaxel.
Propiedades químicas
Consulta técnica sobre: 3D-QUD17242 DT2216
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.